Please login to the form below

Not currently logged in
Email:
Password:

Industry unites to spread CoP word

Reps told to dedicate time to telling doctors how to make a complaint

Reps from 50 pharma firms were yesterday given a slightly different brief - to bombard doctors and other health professionals with information about the ABPI Code of Practice (CoP) that governs their work.

The initiative was part of `Code Day', designed to spread the word about the code, its provisions and how to make a complaint. Reps and other industry employees meeting with health professionals, patient organisations, professional bodies and the media were asked to dedicate some time to discussing the revamped CoP.

Recent ABPI research has found that 48 per cent of doctors interviewed were unaware of the CoP, while 86 per cent had no knowledge of how to make a complaint.

ìI will champion the new code of conduct to ensure that it raises the standard of healthcare in the UK even higher,î said ABPI president, Nigel Brooksby. ìThis industry-wide initiative symbolises our commitment to promoting the code more widely for the benefit of all patients.î

As part of Code Day, doctors were offered information leaflets which clarify the main provisions of the CoP.

Oliver Brandicourt, managing director of Pfizer UK said the firm had asked all its employees to participate to promote the CoP.

Code Day was coordinated by the ABPI and supported by the Medicines and Healthcare products Regulatory Agency, British Medical Association, Royal College of Physicians, Royal College of Nursing, NHS Alliance, and the Royal Pharmaceutical Society of Great Britain.

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics